BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 10, Issue 12
This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (5158)
All Articles published online
The chart showing PDF series, HTML series, Tables (1-6) series.
Item 
Count 
PDF452
HTML4565
Tables (1-6)134
 Sum=5151
Jun 15, 2004 (publication date) through Apr 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Si JM, Yu YC, Fan YJ, Chen SJ. Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol 2004; 10(12): 1802-1805 [PMID: 15188510 DOI: 10.3748/wjg.v10.i12.1802]
URL: https://www.wjgnet.com/1007-9327/full/v10/i12/1802.htm
Number Citing Articles
1
Natalia Zeber-Lubecka, Maria Kulecka, Filip Ambrozkiewicz, Agnieszka Paziewska, Krzysztof Goryca, Jakub Karczmarski, Tymon Rubel, Wojciech Wojtowicz, Piotr Mlynarz, Lukasz Marczak, Roman Tomecki, Michal Mikula, Jerzy Ostrowski. Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome. Gut Microbes 2016; 7(5): 397 doi: 10.1080/19490976.2016.1215805
2
K. J. Lee, J. Tack. Altered intestinal microbiota in irritable bowel syndrome. Neurogastroenterology & Motility 2010; 22(5): 493 doi: 10.1111/j.1365-2982.2010.01482.x
3
Shengtao Zhu, Si Liu, Hengcun Li, Zheng Zhang, Qian Zhang, Lei Chen, Yu Zhao, Yang Chen, Junchao Gu, Li Min, Shutian Zhang. Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome. Frontiers in Cellular and Infection Microbiology 2019; 9 doi: 10.3389/fcimb.2019.00346
4
B. I. Nicholl, S. L. Halder, G. J. Macfarlane, D. G. Thompson, S. O’Brien, M. Musleh, J. McBeth. Psychosocial risk markers for new onset irritable bowel syndrome – Results of a large prospective population-based study. Pain 2008; 137(1): 147 doi: 10.1016/j.pain.2007.08.029
5
Daniele Fraternale, Guido Flamini, Donata Ricci. Essential Oil Composition and Antimicrobial Activity of Angelica archangelica L. (Apiaceae) Roots. Journal of Medicinal Food 2014; 17(9): 1043 doi: 10.1089/jmf.2013.0012
6
Spyridon K. Kritas. Probiotics and Prebiotics in Animal Health and Food Safety. 2018; : 109 doi: 10.1007/978-3-319-71950-4_4
7
Lin Wang, Nuha Alammar, Rajdeep Singh, Julie Nanavati, Yiran Song, Rahul Chaudhary, Gerard E. Mullin. Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies. Journal of the Academy of Nutrition and Dietetics 2020; 120(4): 565 doi: 10.1016/j.jand.2019.05.015
8
Francesca Romana Ponziani, Silvia Pecere, Loris Lopetuso, Franco Scaldaferri, Giovanni Cammarota, Antonio Gasbarrini. Rifaximin for the treatment of irritable bowel syndrome – a drug safety evaluation. Expert Opinion on Drug Safety 2016; 15(7): 983 doi: 10.1080/14740338.2016.1186639
9
Angèle P. M. Kerckhoffs, Kaouther Ben-Amor, Melvin Samsom, Michel E. van der Rest, Joris de Vogel, Jan Knol, Louis M. A. Akkermans. Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome.  Journal of Medical Microbiology 2011; 60(2): 236 doi: 10.1099/jmm.0.022848-0
10
Mirjana Rajilić-Stojanović, Daisy M Jonkers, Anne Salonen, Kurt Hanevik, Jeroen Raes, Jonna Jalanka, Willem M de Vos, Chaysavanh Manichanh, Natasa Golic, Paul Enck, Elena Philippou, Fuad A Iraqi, Gerard Clarke, Robin C Spiller, John Penders. Intestinal Microbiota And Diet in IBS: Causes, Consequences, or Epiphenomena?. American Journal of Gastroenterology 2015; 110(2): 278 doi: 10.1038/ajg.2014.427
11
Haifeng Lu, Zhongwen Wu, Wei Xu, Jiezuan Yang, Yunbo Chen, Lanjuan Li. Intestinal Microbiota Was Assessed in Cirrhotic Patients with Hepatitis B Virus Infection. Microbial Ecology 2011; 61(3): 693 doi: 10.1007/s00248-010-9801-8
12
Darren CR. Fernandes, H. Jervoise N Andreyev. Chronic diarrhoea in an oncology patient – Clinical assessment and decision making. Best Practice & Research Clinical Gastroenterology 2020; : 101708 doi: 10.1016/j.bpg.2020.101708
13
Oscar Rodríguez-Fandiño, Joselín Hernández-Ruiz, Max Schmulson. From Cytokines to Toll-Like Receptors and Beyond - Current Knowledge and Future Research Needs in Irritable Bowel Syndrome. Journal of Neurogastroenterology and Motility 2010; 16(4): 363 doi: 10.5056/jnm.2010.16.4.363
14
Matteo M Pusceddu, Melanie G Gareau. Visceral pain: gut microbiota, a new hope?. Journal of Biomedical Science 2018; 25(1) doi: 10.1186/s12929-018-0476-7
15
Eamonn M.M. Quigley. Review: Do patients with functional gastrointestinal disorders have an altered gut flora?. Therapeutic Advances in Gastroenterology 2009; 2(4_suppl): S23 doi: 10.1177/1756283X09335636
16
S. Guglielmetti, D. Mora, M. Gschwender, K. Popp. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life -- a double-blind, placebo-controlled study. Alimentary Pharmacology & Therapeutics 2011; 33(10): 1123 doi: 10.1111/j.1365-2036.2011.04633.x
17
C. N. Andrews, T. A. Griffiths, J. Kaufman, N. Vergnolle, M. G. Surette, K. P. Rioux. Mesalazine (5‐aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea‐predominant irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 2011; 34(3): 374 doi: 10.1111/j.1365-2036.2011.04732.x
18
Gareth C. Parkes, Jonathan Brostoff, Kevin Whelan, Jeremy D. Sanderson. Gastrointestinal Microbiota in Irritable Bowel Syndrome: Their Role in Its Pathogenesis and Treatment. The American Journal of Gastroenterology 2008; 103(6): 1557 doi: 10.1111/j.1572-0241.2008.01869.x
19
Ana Durbán, Juan J. Abellán, Nuria Jiménez-Hernández, Alejandro Artacho, Vicente Garrigues, Vicente Ortiz, Julio Ponce, Amparo Latorre, Andrés Moya. Instability of the faecal microbiota in diarrhoea-predominant irritable bowel syndrome. FEMS Microbiology Ecology 2013; 86(3): 581 doi: 10.1111/1574-6941.12184
20
Wenting Wen, Haibo Zhang, Junlong Shen, Luxia Wei, Shunong Shen. Fecal microbiota transplantation for patients with irritable bowel syndrome. Medicine 2018; 97(40): e12661 doi: 10.1097/MD.0000000000012661
21
Pei Pei Chong, Voon Kin Chin, Chung Yeng Looi, Won Fen Wong, Priya Madhavan, Voon Chen Yong. The Microbiome and Irritable Bowel Syndrome – A Review on the Pathophysiology, Current Research and Future Therapy. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.01136
22
Priyankar Dey. Gut microbiota in phytopharmacology: A comprehensive overview of concepts, reciprocal interactions, biotransformations and mode of actions. Pharmacological Research 2019; 147: 104367 doi: 10.1016/j.phrs.2019.104367
23
Ronald J. Ellis, Robert K. Heaton, Sara Gianella, Gibraan Rahman, Rob Knight. Reduced Gut Microbiome Diversity in People With HIV Who Have Distal Neuropathic Pain. The Journal of Pain 2022; 23(2): 318 doi: 10.1016/j.jpain.2021.08.006
24
A. V. S. Perumalla, L. A. Wythe, Steven C. Ricke. Direct-Fed Microbials and Prebiotics for Animals. 2023; : 127 doi: 10.1007/978-3-031-40512-9_7
25
Lena Öhman, Hans Törnblom, Magnus Simrén. Crosstalk at the mucosal border: importance of the gut microenvironment in IBS. Nature Reviews Gastroenterology & Hepatology 2015; 12(1): 36 doi: 10.1038/nrgastro.2014.200
26
Yehuda Ringel, Ian M. Carroll. Alterations in the Intestinal Microbiota and Functional Bowel Symptoms. Gastrointestinal Endoscopy Clinics of North America 2009; 19(1): 141 doi: 10.1016/j.giec.2008.12.004
27
Anna Lyra, Teemu Rinttilä, Janne Nikkilä, Lotta Krogius-Kurikka, Kajsa Kajander, Erja Malinen, Jaana Mättö, Laura Mäkelä, Airi Palva. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. World Journal of Gastroenterology 2009; 15(47): 5936-5945 doi: 10.3748/wjg.15.5936
28
Lei-Min Yu, Ke-Jia Zhao, Shuang-Shuang Wang, Xi Wang, Bin Lu. Gas chromatography/mass spectrometry based metabolomic study in a murine model of irritable bowel syndrome. World Journal of Gastroenterology 2018; 24(8): 894-904 doi: 10.3748/wjg.v24.i8.894
29
Daniele Fraternale, Salvatore Genovese, Donata Ricci. Essential Oil Composition and Antimicrobial Activity of Aerial Parts and Ripe Fruits of Echinophora spinosa (Apiaceae) from Italy. Natural Product Communications 2013; 8(4): 1934578X1300800 doi: 10.1177/1934578X1300800431
30
Ian M. Carroll, Tamar Ringel-Kulka, Temitope O. Keku, Young-Hyo Chang, Christopher D. Packey, R. Balfour Sartor, Yehuda Ringel. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. American Journal of Physiology-Gastrointestinal and Liver Physiology 2011; 301(5): G799 doi: 10.1152/ajpgi.00154.2011
31
Qiaoqiao Lu, Jianbo Lai, Haifeng Lu, Chee Ng, Tingting Huang, Hua Zhang, Kaijing Ding, Zheng Wang, Jiajun Jiang, Jianbo Hu, Jing Lu, Shaojia Lu, Tingting Mou, Dandan Wang, Yanli Du, Caixi Xi, Hailong Lyu, Jingkai Chen, Yi Xu, Zhuhua Liu, Shaohua Hu. Gut Microbiota in Bipolar Depression and Its Relationship to Brain Function: An Advanced Exploration. Frontiers in Psychiatry 2019; 10 doi: 10.3389/fpsyt.2019.00784
32
Eamonn M M QUIGLEY. Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management. Journal of Digestive Diseases 2007; 8(1): 2 doi: 10.1111/j.1443-9573.2007.00277.x
33
A. V. S. Perumalla, Navam S. Hettiarachchy, Steven C. Ricke. Direct-Fed Microbials and Prebiotics for Animals. 2012; : 89 doi: 10.1007/978-1-4614-1311-0_7
34
M. Schmulson, M.V. Bielsa, R. Carmona-Sánchez, A. Hernández, A. López-Colombo, Y. López Vidal, M. Peláez-Luna, J.M. Remes-Troche, J.L. Tamayo, M.A. Valdovinos. Microbiota, infecciones gastrointestinales, inflamación de bajo grado y antibioticoterapia en el síndrome de intestino irritable. Una revisión basada en evidencias. Revista de Gastroenterología de México 2014; 79(2): 96 doi: 10.1016/j.rgmx.2014.01.004
35
Guanqun Chao, Shuo Zhang. The characteristics of intestinal flora of IBS‐D with different syndromes. Immunity, Inflammation and Disease 2020; 8(4): 615 doi: 10.1002/iid3.348
36
Uday C. Ghoshal, Ratnakar Shukla, Ujjala Ghoshal, Kok-Ann Gwee, Siew C. Ng, Eamonn M. M. Quigley. The Gut Microbiota and Irritable Bowel Syndrome: Friend or Foe?. International Journal of Inflammation 2012; 2012: 1 doi: 10.1155/2012/151085
37
G. C. Parkes, J. D. Sanderson, K. Whelan. Treating irritable bowel syndrome with probiotics: the evidence. Proceedings of the Nutrition Society 2010; 69(2): 187 doi: 10.1017/S002966511000011X
38
David E. Saslowsky, Noriyuki Tanaka, Krishna P. Reddy, Wayne I. Lencer. Ceramide activates JNK to inhibit a cAMP‐gated K + conductance and Cl ‐ secretion in intestinal epithelia . The FASEB Journal 2009; 23(1): 259 doi: 10.1096/fj.08-116467
39
Laetitia Rodes, Arghya Paul, Michael Coussa-Charley, Hani Al-Salami, Catherine Tomaro-Duchesneau, Marc Fakhoury, Satya Prakash. Transit Time Affects the Community Stability ofLactobacillusandBifidobacteriumSpecies in anIn VitroModel of Human Colonic Microbiotia. Artificial Cells, Blood Substitutes, and Biotechnology 2011; 39(6): 351 doi: 10.3109/10731199.2011.622280
40
L. Crouzet, E. Gaultier, C. Del'Homme, C. Cartier, E. Delmas, M. Dapoigny, J. Fioramonti, A. Bernalier‐Donadille. The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota. Neurogastroenterology & Motility 2013; 25(4) doi: 10.1111/nmo.12103
41
Hélène Eutamene, Florence Lamine, Chantal Chabo, Vassilia Theodorou, Florence Rochat, Gabriela E. Bergonzelli, Irène Corthésy-Theulaz, Jean Fioramonti, Lionel Bueno. Synergy between Lactobacillus paracasei and Its Bacterial Products to Counteract Stress-Induced Gut Permeability and Sensitivity Increase in Rats ,. The Journal of Nutrition 2007; 137(8): 1901 doi: 10.1093/jn/137.8.1901
42
Liang Xu, Feng Ji. Infectious Microecology. Advanced Topics in Science and Technology in China 2014; : 293 doi: 10.1007/978-3-662-43883-1_11
43
Ji-Wei Zhang, Peng Du, Bao-Ren Yang, Jun Gao, Wei-Jia Fang, Chun-Mei Ying. Preoperative Probiotics Decrease Postoperative Infectious Complications of Colorectal Cancer. The American Journal of the Medical Sciences 2012; 343(3): 199 doi: 10.1097/MAJ.0b013e31823aace6
44
Stephen M Riordan, Robert Kim. Bacterial overgrowth as a cause of irritable bowel syndrome. Current Opinion in Gastroenterology 2006; 22(6): 669 doi: 10.1097/01.mog.0000245544.80160.46
45
Ray Pak, Michelle Cho, Keth Pride, Alaa Abd-Elsayed. The Gut Microbiota and Chronic Pain. Current Pain and Headache Reports 2024; 28(4): 259 doi: 10.1007/s11916-024-01221-x
46
D. M. Pinn, O. C. Aroniadis, L. J. Brandt. Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)?. Neurogastroenterology & Motility 2015; 27(1): 19 doi: 10.1111/nmo.12479
47
Cristina M. SABO, Dan L. DUMITRASCU. Microbiota and the irritable bowel syndrome. Minerva Gastroenterology 2022; 67(4) doi: 10.23736/S2724-5985.21.02923-5
48
G. C. Parkes, N. B. Rayment, B. N. Hudspith, L. Petrovska, M. C. Lomer, J. Brostoff, K. Whelan, J. D. Sanderson. Distinct microbial populations exist in the mucosa‐associated microbiota of sub‐groups of irritable bowel syndrome. Neurogastroenterology & Motility 2012; 24(1): 31 doi: 10.1111/j.1365-2982.2011.01803.x
49
Larysa Hun. Original Research:Bacillus coagulansSignificantly Improved Abdominal Pain and Bloating in Patients with IBS. Postgraduate Medicine 2009; 121(2): 119 doi: 10.3810/pgm.2009.03.1984
50
Marika Björklund, Arthur C. Ouwehand, Sofia D. Forssten, Janne Nikkilä, Kirsti Tiihonen, Nina Rautonen, Sampo J. Lahtinen. Gut microbiota of healthy elderly NSAID users is selectively modified with the administration of Lactobacillus acidophilus NCFM and lactitol. AGE 2012; 34(4): 987 doi: 10.1007/s11357-011-9294-5
51
Neeraj Kabra, Abhijit Nadkarni. Prevalence of depression and anxiety in irritable bowel syndrome: A clinic based study from India. Indian Journal of Psychiatry 2013; 55(1): 77 doi: 10.4103/0019-5545.105520
52
Chul Sang Lee, Pei Lei Tan, Ju Young Eor, Da Hye Choi, Miri Park, Sung Keum Seo, Seokmin Yoon, Siyoung Yang, Sae Hun Kim. Prophylactic use of probiotic chocolate modulates intestinal physiological functions in constipated rats. Journal of the Science of Food and Agriculture 2019; 99(6): 3045 doi: 10.1002/jsfa.9518
53
Nathan J. Rogers, Shaker A. Mousa. The Shortcomings of Clinical Trials Assessing the Efficacy of Probiotics in Irritable Bowel Syndrome. The Journal of Alternative and Complementary Medicine 2012; 18(2): 112 doi: 10.1089/acm.2011.0015
54
Nima Mohammadzadeh, Behrooz Sadeghi Kalani, Shahin Bolori, Azadeh Azadegan, Afsaneh Gholami, Rokhsareh Mohammadzadeh, Faramarz Masjedian Jazi. Identification of an intestinal microbiota signature associated with hospitalized patients with diarrhea. Acta Microbiologica et Immunologica Hungarica 2019; 66(2): 189 doi: 10.1556/030.66.2019.002
55
Eamonn M M Quigley. Probiotics in Irritable Bowel Syndrome: An Immunomodulatory Strategy?. Journal of the American College of Nutrition 2007; 26(6): 684S doi: 10.1080/07315724.2007.10719648
56
Sonia Michail. Probiotics in Pediatric Medicine. 2009; : 131 doi: 10.1007/978-1-60327-289-6_10
57
Beom Jae Lee, Young-Tae Bak. Irritable Bowel Syndrome, Gut Microbiota and Probiotics. Journal of Neurogastroenterology and Motility 2011; 17(3): 252 doi: 10.5056/jnm.2011.17.3.252
58
Bryan Tungland. Human Microbiota in Health and Disease. 2018; : 197 doi: 10.1016/B978-0-12-814649-1.00006-5
59
Giovanni Bruno, Piera Zaccari, Giulia Rocco, Giulia Scalese, Cristina Panetta, Barbara Porowska, Stefano Pontone, Carola Severi. Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified. World Journal of Gastroenterology 2019; 25(22): 2706-2719 doi: 10.3748/wjg.v25.i22.2706
60
Zhen Yuan, Lan Shu, Xin-Xin Peng, Zhou-Jin Tan. Influence of Tongxie formula on intestinal microorganisms. World Chinese Journal of Digestology 2020; 28(10): 357 doi: 10.11569/wcjd.v28.i10.357
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
61
Joo Hyun Oh, Yeon Sil Jang, Danbee Kang, Hong Seog Kim, Eui-Joong Kim, So-Young Park, Cheol-Hyun Kim, Yang Won Min, Dong Kyung Chang. Efficacy of a Synbiotic Containing Lactobacillus paracasei DKGF1 and Opuntia humifusa in Elderly Patients with Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Gut and Liver 2023; 17(1): 100 doi: 10.5009/gnl210478
62
Emeran A. Mayer, Tor Savidge, Robert J. Shulman. Brain–Gut Microbiome Interactions and Functional Bowel Disorders. Gastroenterology 2014; 146(6): 1500 doi: 10.1053/j.gastro.2014.02.037
63
Magdy El-Salhy, Tarek Mazzawi. Fecal microbiota transplantation for managing irritable bowel syndrome. Expert Review of Gastroenterology & Hepatology 2018; 12(5): 439 doi: 10.1080/17474124.2018.1447380
64
A. TURSI, S. PAPAGRIGORIADIS. Review article: the current and evolving treatment of colonic diverticular disease. Alimentary Pharmacology & Therapeutics 2009; 30(6): 532 doi: 10.1111/j.1365-2036.2009.04072.x
65
Julia König, Ignacio Rangel, Robert J. Brummer. The Role of Lactic Acid Bacteria in the Pathophysiology and Treatment of Irritable Bowel Syndrome (IBS). Food and Nutrition Sciences 2013; 4(11): 27 doi: 10.4236/fns.2013.411A005
66
MAGDY EL-SALHY, ODD HELGE GILJA, DORIS GUNDERSEN, JAN G. HATLEBAKK, TRYGVE HAUSKEN. Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (Review). International Journal of Molecular Medicine 2014; 34(2): 363 doi: 10.3892/ijmm.2014.1811
67
Lingxiao Gong, Hongna Wang, Tianxi Wang, Yingli Liu, Jing Wang, Baoguo Sun. Feruloylated oligosaccharides modulate the gut microbiota in vitro via the combined actions of oligosaccharides and ferulic acid. Journal of Functional Foods 2019; 60: 103453 doi: 10.1016/j.jff.2019.103453
68
Xiuwen Xia, Ya Xie, Qiaoqiao Chen, Dou Ding, Zongqin Wang, Yaji Xu, Yili Wang, Xiumin Wang, Weijun Ding. Cocultivation of Chinese prescription and intestine microbiota: SJZD alleviated the major symptoms of IBS-D subjects by tuning neurotransmitter metabolism. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1053103
69
Anna Kassinen, Lotta Krogius-Kurikka, Harri Mäkivuokko, Teemu Rinttilä, Lars Paulin, Jukka Corander, Erja Malinen, Juha Apajalahti, Airi Palva. The Fecal Microbiota of Irritable Bowel Syndrome Patients Differs Significantly From That of Healthy Subjects. Gastroenterology 2007; 133(1): 24 doi: 10.1053/j.gastro.2007.04.005
70
Takao Yamane, Ayako Miyajima, Kazuha Hatta, Toshihiro Fujita, Naohiro Soga, Shingo Kameoka. Two Cases of Improvement of Diarrheal Irritable Bowel Syndrome Symptoms Following Appendectomy. Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons) 2017; 42(6): 952 doi: 10.4030/jjcs.42.952
71
K. KAJANDER, L. KROGIUS‐KURIKKA, T. RINTTILÄ, H. KARJALAINEN, A. PALVA, R. KORPELA. Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 2007; 26(3): 463 doi: 10.1111/j.1365-2036.2007.03391.x
72
Guido J. Bakker, Max Nieuwdorp, Robert Allen Britton, Patrice D. Cani. Fecal Microbiota Transplantation: Therapeutic Potential for a Multitude of Diseases beyond Clostridium difficile . Microbiology Spectrum 2017; 5(4) doi: 10.1128/microbiolspec.BAD-0008-2017
73
Ahmed E. Salem, Rajdeep Singh, Younan K. Ayoub, Ahmed M. Khairy, Gerard E. Mullin. The gut microbiome and irritable bowel syndrome: State of art review. Arab Journal of Gastroenterology 2018; 19(3): 136 doi: 10.1016/j.ajg.2018.02.008
74
Franco Scaldaferri, Marco Pizzoferrato, Silvia Pecere, Fabrizio Forte, Antonio Gasbarrini. Bacterial Flora as a Cause or Treatment of Chronic Diarrhea. Gastroenterology Clinics of North America 2012; 41(3): 581 doi: 10.1016/j.gtc.2012.06.002
75
Wanxiu Cao, Chengcheng Wang, Yaoxian Chin, Xin Chen, Yuan Gao, Shihan Yuan, Changhu Xue, Yuming Wang, Qingjuan Tang. DHA-phospholipids (DHA-PL) and EPA-phospholipids (EPA-PL) prevent intestinal dysfunction induced by chronic stress. Food & Function 2019; 10(1): 277 doi: 10.1039/C8FO01404C
76
Suma S Magge, Jacqueline L Wolf. Complementary and Alternative Medicine and Mind–Body Therapies for Treatment of Irritable Bowel Syndrome in Women. Women's Health 2013; 9(6): 557 doi: 10.2217/WHE.13.57
77
Tarek Mazzawi, Magdy El-Salhy, Gülen Arslan Lied, Trygve Hausken. The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome. Frontiers in Cellular and Infection Microbiology 2021; 11 doi: 10.3389/fcimb.2021.524851
78
Gareth C. Parkes. Bioactive Foods in Promoting Health. 2010; : 513 doi: 10.1016/B978-0-12-374938-3.00030-X
79
E. Myllyluoma, K. Kajander, M. Saxelin. Functional Dairy Products. 2007; : 63 doi: 10.1533/9781845693107.1.63
80
Seok-Jae Ko, Jinsung Kim, Gajin Han, Seul-Ki Kim, Hong-Geol Kim, Inkwon Yeo, Bongha Ryu, Jae-Woo Park. Laminaria japonica Combined with Probiotics Improves Intestinal Microbiota: A Randomized Clinical Trial. Journal of Medicinal Food 2014; 17(1): 76 doi: 10.1089/jmf.2013.3054
81
I. M. Carroll, T. Ringel‐Kulka, J. P. Siddle, Y. Ringel. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea‐predominant irritable bowel syndrome. Neurogastroenterology & Motility 2012; 24(6): 521 doi: 10.1111/j.1365-2982.2012.01891.x
82
Adam D. Farmer, Qasim Aziz. Advanced Nutrition and Dietetics in Gastroenterology. 2014; : 226 doi: 10.1002/9781118872796.ch3.18
83
Max Schmulson, María Victoria Bielsa, Ramón Carmona-Sánchez, Angélica Hernández, Aurelio López-Colombo, Yolanda López Vidal, Mario Peláez-Luna, José María Remes-Troche, José Luis Tamayo, Miguel Angel Valdovinos. Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome (IBS): an evidence-based review. Revista de Gastroenterología de México (English Edition) 2014; 79(2): 96 doi: 10.1016/j.rgmxen.2014.01.001
84
Magdy El-Salhy. Recent developments in the pathophysiology of irritable bowel syndrome. World Journal of Gastroenterology 2015; 21(25): 7621-7636 doi: 10.3748/wjg.v21.i25.7621
85
Lorenza Putignani, Federica Del Chierico, Pamela Vernocchi, Michele Cicala, Salvatore Cucchiara, Bruno Dallapiccola. Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood–Adulthood Transition. Inflammatory Bowel Diseases 2016; 22(2): 487 doi: 10.1097/MIB.0000000000000602
86
Carolina M. Bolino, Premysl Bercik. Pathogenic Factors Involved in the Development of Irritable Bowel Syndrome: Focus on a Microbial Role. Infectious Disease Clinics of North America 2010; 24(4): 961 doi: 10.1016/j.idc.2010.07.005
87
Lotta Krogius-Kurikka, Anna Lyra, Erja Malinen, Johannes Aarnikunnas, Jarno Tuimala, Lars Paulin, Harri Mäkivuokko, Kajsa Kajander, Airi Palva. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterology 2009; 9(1) doi: 10.1186/1471-230X-9-95
88
L. Foster, T. Tompkins, W. Dahl. A comprehensive post-market review of studies on a probiotic product containing Lactobacillus helveticus R0052 and Lactobacillus rhamnosus R0011. Beneficial Microbes 2011; 2(4): 319 doi: 10.3920/BM2011.0032
89
Jiayi Chen, Xiaoji Zhu, Yang Peng, Huirong Liu, Huangan Wu, Cili Zhou. Effects of moxibustion on behaviors and tryptophan metabolism-related products in mice with irritable bowel syndrome. Journal of Acupuncture and Tuina Science 2023; 21(2): 91 doi: 10.1007/s11726-023-1366-4
90
T. Piche. Anomalies pariétales et de la flore au cours du syndrome de l’intestin irritable. Gastroentérologie Clinique et Biologique 2009; 33: S40 doi: 10.1016/S0399-8320(09)71524-6
91
Ian M Carroll, Young-Hyo Chang, Jiwon Park, R Balfour Sartor, Yehuda Ringel. Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Gut Pathogens 2010; 2(1) doi: 10.1186/1757-4749-2-19
92
Robin Spiller, Ching Lam. An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome. Journal of Neurogastroenterology and Motility 2012; 18(3): 258 doi: 10.5056/jnm.2012.18.3.258
93
Maciej Chichlowski, Colin Rudolph. Visceral Pain and Gastrointestinal Microbiome. Journal of Neurogastroenterology and Motility 2015; 21(2): 172 doi: 10.5056/jnm15025
94
Mark Pimentel, Christopher Chang. Inflammation and Microflora. Gastroenterology Clinics of North America 2011; 40(1): 69 doi: 10.1016/j.gtc.2010.12.010
95
Chiranjit Maity, Atanu Adak, Tarun Kumar Pathak, Bikas Ranjan Pati, Keshab Chandra Mondal. Study of the cultivable microflora of the large intestine of the rat under varied environmental hyperbaric pressures. Journal of Microbiology, Immunology and Infection 2012; 45(4): 281 doi: 10.1016/j.jmii.2011.12.002
96
Jessica R Biesiekierski, Jonna Jalanka, Heidi M Staudacher. Can Gut Microbiota Composition Predict Response to Dietary Treatments?. Nutrients 2019; 11(5): 1134 doi: 10.3390/nu11051134
97
Seok-Jae Ko, Bongha Ryu, Jinsung Kim, Beom-Gi Hong, Inkwon Yeo, Beom-Joon Lee, Jin-Moo Lee, Jae-Woo Park. Effect of herbal extract granules combined with probiotic mixture on irritable bowel syndrome with diarrhea: study protocol for a randomized controlled trial. Trials 2011; 12(1) doi: 10.1186/1745-6215-12-219
98
Yao Wang, Fengling Zheng, Shan Liu, Huanhuan Luo. Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome. Gastroenterology Research and Practice 2019; 2019: 1 doi: 10.1155/2019/9759138
99
C. Bucci, A. Santonicola, P. Iovino. Probiotics, Prebiotics, and Synbiotics. 2016; : 557 doi: 10.1016/B978-0-12-802189-7.00040-X
100
L. Öhman, M. Simrén. New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Digestive and Liver Disease 2007; 39(3): 201 doi: 10.1016/j.dld.2006.10.014
101
Yogesh Bhattarai, David A. Muniz Pedrogo, Purna C. Kashyap. Irritable bowel syndrome: a gut microbiota-related disorder?. American Journal of Physiology-Gastrointestinal and Liver Physiology 2017; 312(1): G52 doi: 10.1152/ajpgi.00338.2016
102
Tarek Mazzawi, Magdy El-Salhy. Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review). International Journal of Molecular Medicine 2017; 40(4): 943 doi: 10.3892/ijmm.2017.3096
103
Guido J. Bakker, Max Nieuwdorp. Bugs as Drugs. 2018; : 291 doi: 10.1128/9781555819705.ch12
104
Eamonn M M Quigley. Microflora Modulation of Motility. Journal of Neurogastroenterology and Motility 2011; 17(2): 140 doi: 10.5056/jnm.2011.17.2.140
105
Senthil Alias Sankar, Jean-Christophe Lagier, Pierre Pontarotti, Didier Raoult, Pierre-Edouard Fournier. The human gut microbiome, a taxonomic conundrum. Systematic and Applied Microbiology 2015; 38(4): 276 doi: 10.1016/j.syapm.2015.03.004
106
Eamonn M. M. Quigley. The Efficacy of Probiotics in IBS. Journal of Clinical Gastroenterology 2008; 42(Supplement 2): S85 doi: 10.1097/MCG.0b013e31816244ca
107
Francesca Gaggìa, Paola Mattarelli, Bruno Biavati. Probiotics and prebiotics in animal feeding for safe food production. International Journal of Food Microbiology 2010; 141: S15 doi: 10.1016/j.ijfoodmicro.2010.02.031
108
Uday C. Ghoshal, Deepakshi Srivastava, Asha Misra, Ujjala Ghoshal. A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth. European Journal of Gastroenterology & Hepatology 2016; 28(3): 281 doi: 10.1097/MEG.0000000000000557
109
Jingjie Li, Wen Zhang, Chuan Wang, Qian Yu, Ruirui Dai, Xiaofang Pei. Lactococcus lactis expressing food-grade β-galactosidase alleviates lactose intolerance symptoms in post-weaning Balb/c mice. Applied Microbiology and Biotechnology 2012; 96(6): 1499 doi: 10.1007/s00253-012-3977-4
110
Eamonn M. M. Quigley, Hussein Abdel-Hamid, Giovanni Barbara, Shobna J. Bhatia, Guy Boeckxstaens, Roberto De Giorgio, Michel Delvaux, Douglas A. Drossman, Amy E. Foxx-Orenstein, Francisco Guarner, Kok-Ann Gwee, Lucinda A. Harris, A. Pali S. Hungin, Richard H. Hunt, John E. Kellow, Igor L. Khalif, Wolfgang Kruis, Greger Lindberg, Carolina Olano, Joaquim P. Moraes-Filho, Lawrence R. Schiller, Max Schmulson, Magnus Simrén, Christian Tzeuton. A Global Perspective on Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 2012; 46(5): 356 doi: 10.1097/MCG.0b013e318247157c
111
Thalita Mázala-de-Oliveira, Yago Amigo Pinho Jannini de Sá, Vinicius de Frias Carvalho. Impact of gut-peripheral nervous system axis on the development of diabetic neuropathy. Memórias do Instituto Oswaldo Cruz 2023; 118 doi: 10.1590/0074-02760220197
112
Ashraf MORCOS, Ted DINAN, Eamonn MM QUIGLEY. Irritable bowel syndrome: Role of food in pathogenesis and management. Journal of Digestive Diseases 2009; 10(4): 237 doi: 10.1111/j.1751-2980.2009.00392.x
113
L. öhman, A.‐c. Lindmark, S. Isaksson, I. Posserud, H. Strid, H. Sjövall, M. Simrén. B‐cell activation in patients with irritable bowel syndrome (IBS). Neurogastroenterology & Motility 2009; 21(6): 644 doi: 10.1111/j.1365-2982.2009.01272.x
114
Eamonn M.M. Quigley. Bacteria: A New Player in Gastrointestinal Motility Disorders—Infections, Bacterial Overgrowth, and Probiotics. Gastroenterology Clinics of North America 2007; 36(3): 735 doi: 10.1016/j.gtc.2007.07.012
115
Eleonora Distrutti, Lorenzo Monaldi, Patrizia Ricci, Stefano Fiorucci. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World Journal of Gastroenterology 2016; 22(7): 2219-2241 doi: 10.3748/wjg.v22.i7.2219
116
Eamonn M.M. Quigley. The Use of Probiotics in Functional Bowel Disease. Gastroenterology Clinics of North America 2005; 34(3): 533 doi: 10.1016/j.gtc.2005.05.008
117
Oleg Jadrešin, Iva Hojsak, Zrinjka Mišak, Alemka Jaklin Kekez, Tena Trbojević, Lana Ivković, Sanja Kolaček. Lactobacillus reuteri DSM 17938 in the Treatment of Functional Abdominal Pain in Children. Journal of Pediatric Gastroenterology and Nutrition 2017; 64(6): 925 doi: 10.1097/MPG.0000000000001478
118
Damien Paineau, Flore Payen, Suzanne Panserieu, Geneviève Coulombier, Annie Sobaszek, Isabelle Lartigau, Marylène Brabet, Jean-Paul Galmiche, Dominique Tripodi, Sylvie Sacher-Huvelin, Véronique Chapalain, Othar Zourabichvili, Frédérique Respondek, Anne Wagner, Francis R. J. Bornet. The effects of regular consumption of short-chain fructo-oligosaccharides on digestive comfort of subjects with minor functional bowel disorders. British Journal of Nutrition 2008; 99(2): 311 doi: 10.1017/S000711450779894X
119
Xiaojie Yuan, Yong Long, Zhaohua Ji, Jie Gao, Ting Fu, Min Yan, Lei Zhang, Haixia Su, Weilu Zhang, Xiaohui Wen, Zhongshu Pu, Hui Chen, Yufei Wang, Xu Gu, Binyuan Yan, Kanakaraju Kaliannan, Zhongjun Shao. Green Tea Liquid Consumption Alters the Human Intestinal and Oral Microbiome. Molecular Nutrition & Food Research 2018; 62(12) doi: 10.1002/mnfr.201800178
120
Beatriz Míguez, Carlos Vila, Koen Venema, Juan C. Parajó, José L. Alonso. Potential of High- and Low-Acetylated Galactoglucomannooligosaccharides as Modulators of the Microbiota Composition and Their Activity: A Comparison Using the In Vitro Model of the Human Colon TIM-2. Journal of Agricultural and Food Chemistry 2020; 68(29): 7617 doi: 10.1021/acs.jafc.0c02225
121
Peter J. Whorwell. Review: Do probiotics improve symptoms in patients with irritable bowel syndrome?. Therapeutic Advances in Gastroenterology 2009; 2(4_suppl): S37 doi: 10.1177/1756283X09335637
122
Nirit Keren, Uri Gophna. Beneficial Microorganisms in Multicellular Life Forms. 2012; : 211 doi: 10.1007/978-3-642-21680-0_15
123
Magdy El-Salhy. Recent advances in the diagnosis of irritable bowel syndrome. Expert Review of Gastroenterology & Hepatology 2015; 9(9): 1161 doi: 10.1586/17474124.2015.1067138
124
Adam M. Nelson, Seth T. Walk, Stefan Taube, Mami Taniuchi, Eric R. Houpt, Christiane E. Wobus, Vincent B. Young, Yolanda Sanz. Disruption of the Human Gut Microbiota following Norovirus Infection. PLoS ONE 2012; 7(10): e48224 doi: 10.1371/journal.pone.0048224
125
Darla D. O'Dwyer, Ray L. Darville. Specific carbohydrate diet: irritable bowel syndrome patient case study. Nutrition & Food Science 2015; 45(6): 859 doi: 10.1108/NFS-05-2015-0056
126
Seok-Jae Ko, Gajin Han, Seul-Ki Kim, Jae-Gu Seo, Won-Seok Chung, Bongha Ryu, Jinsung Kim, Inkwon Yeo, Beom-Joon Lee, Jin-Moo Lee, Jae-Woo Park. Effect of Korean Herbal Medicine Combined with a Probiotic Mixture on Diarrhea-Dominant Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled Trial. Evidence-Based Complementary and Alternative Medicine 2013; 2013: 1 doi: 10.1155/2013/824605
127
Naghmeh Salarieh, Armitasadat Emami Meibodi, Samira Alipour, Masoumeh Azimirad, Mehdi Azizmohammad Looha, Hamid Asadzadeh Aghdaei, Abbas Yadegar, Shabnam Shahrokh, Mohammad Reza Zali. Characterization of the mucosal microbiota in patients with nodular lymphoid hyperplasia with concurrent irritable bowel syndrome compared to healthy controls. Molecular Biology Reports 2023; 50(1): 145 doi: 10.1007/s11033-022-07974-1
128
Hyun Deok Noh, Min Jeong Kim, Im Hak Cho, So Yeon Kim. Review on the Objective Effect and Mechanism Studies of Herbal Medicine, Acupuncture and Moxibustion Treatment for Irritable Bowel Syndrome Patients. Journal of Physiology & Pathology in Korean Medicine 2021; 35(5): 199 doi: 10.15188/kjopp.2021.10.35.5.199
129
Sonia Michail, Mun-Wah Ng. Pediatric Neurogastroenterology. 2013; : 49 doi: 10.1007/978-1-60761-709-9_5
130
Elizabeth Dent, Nicola Davinson, Stephanie Wilkie. The impact of gastrointestinal conditions on psychosocial factors associated with the biopsychosocial model of health: A scoping review. Applied Psychology: Health and Well-Being 2022; 14(2): 626 doi: 10.1111/aphw.12323
131
Qian Chen, Yiping Ren, Jihong Lu, Mark Bartlett, Lei Chen, Yan Zhang, Xiaokui Guo, Chang Liu. A Novel Prebiotic Blend Product Prevents Irritable Bowel Syndrome in Mice by Improving Gut Microbiota and Modulating Immune Response. Nutrients 2017; 9(12): 1341 doi: 10.3390/nu9121341
132
David E. Saslowsky, Jay R. Thiagarajah, Beth A. McCormick, Jean C. Lee, Wayne I. Lencer, Robert G. Parton. Microbial sphingomyelinase induces RhoA-mediated reorganization of the apical brush border membrane and is protective against invasion. Molecular Biology of the Cell 2016; 27(7): 1120 doi: 10.1091/mbc.E15-05-0293
133
Jasmohan S. Bajaj, Giovanni Barbara, Herbert L. DuPont, F. Mearin, Antonio Gasbarrini, Jan Tack. New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases. Digestive and Liver Disease 2018; 50(8): 741 doi: 10.1016/j.dld.2018.04.020
134
Eamonn MM Quigley. Changing face of irritable bowel syndrome. World Journal of Gastroenterology 2006; 12(1): 1-5 doi: 10.3748/wjg.v12.i1.1
135
Hee-Young Kim, Eui-Seong Park, Young Sik Choi, Seun Ja Park, Jae Hyun Kim, Hee Kyung Chang, Kun-Young Park. Kimchi improves irritable bowel syndrome: results of a randomized, double-blind placebo-controlled study. Food & Nutrition Research 2022; 66 doi: 10.29219/fnr.v66.8268
136
M Guslandi. Probiotic Agents in the Treatment of Irritable Bowel Syndrome. Journal of International Medical Research 2007; 35(5): 583 doi: 10.1177/147323000703500501
137
Andrew R. Nafarin, Badriul Hegar, Hikari A. Sjakti, Yvan Vandenplas. Gut microbiome pattern in adolescents with functional gastrointestinal disease. International Journal of Pediatrics and Adolescent Medicine 2019; 6(1): 12 doi: 10.1016/j.ijpam.2019.01.005
138
Yun-Shan He, Hua-Ying Hui, Zhou-Jin Tan. Role of intestinal flora characteristics in traditional Chinese medicine-based diagnosis and treatment of spleen and stomach diseases. World Chinese Journal of Digestology 2019; 27(10): 605 doi: 10.11569/wcjd.v27.i10.605
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
139
Marcel Roberfroid, Glenn R. Gibson, Lesley Hoyles, Anne L. McCartney, Robert Rastall, Ian Rowland, Danielle Wolvers, Bernhard Watzl, Hania Szajewska, Bernd Stahl, Francisco Guarner, Frederique Respondek, Kevin Whelan, Veronique Coxam, Marie-Jeanne Davicco, Laurent Léotoing, Yohann Wittrant, Nathalie M. Delzenne, Patrice D. Cani, Audrey M. Neyrinck, Agnes Meheust. Prebiotic effects: metabolic and health benefits. British Journal of Nutrition 2010; 104(S2): S1 doi: 10.1017/S0007114510003363
140
Likun Zhong, Xiaohua Hou. Pathophysiologic Findings of Irritable Bowel Syndrome in China. Journal of Neurogastroenterology and Motility 2012; 18(1): 19 doi: 10.5056/jnm.2012.18.1.19
141
I. Qureshi, J.R. Endres. Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease. 2013; : 215 doi: 10.1016/B978-0-12-397154-8.00027-0
142
Giada De Palma, Stephen M Collins, Premysl Bercik. The microbiota-gut-brain axis in functional gastrointestinal disorders. Gut Microbes 2014; 5(3): 419 doi: 10.4161/gmic.29417
143
Sean M.P. Bennet, Lena Ohman, Magnus Simren. Gut Microbiota as Potential Orchestrators of Irritable Bowel Syndrome. Gut and Liver 2015; 9(3) doi: 10.5009/gnl14344
144
Rachel J. Gibson, Dorothy M. K. Keefe. Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies. Supportive Care in Cancer 2006; 14(9): 890 doi: 10.1007/s00520-006-0040-y
145
Shrilakshmi Hegde, You-Min Lin, George Golovko, Kamil Khanipov, Yingzi Cong, Tor Savidge, Yuriy Fofanov, Xuan-Zheng Shi. Microbiota dysbiosis and its pathophysiological significance in bowel obstruction. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-31033-0
146
Mahmoud A. ALI. The Relationship Between Affective Disorders and Pain: Focusing on the Functional Gastrointesinal Disorders such as Irritable Bowel Syndrome. Annals of the Academy of Romanian Scientists Series on Biological Sciences 2020; 9(2): 50 doi: 10.56082/annalsarscibio.2020.2.50
147
Nidhi M. Sagar, Ian A. Cree, James A. Covington, Ramesh P. Arasaradnam. The Interplay of the Gut Microbiome, Bile Acids, and Volatile Organic Compounds. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/398585
148
Marta Zielińska. Introduction to Gastrointestinal Diseases Vol. 1. 2017; : 63 doi: 10.1007/978-3-319-49016-8_5
149
L. Bueno, F. De Ponti, M. Fried, G. A. Kullak‐ublick, M. A. Kwiatek, D. Pohl, E. M. M. Quigley, J. Tack, N. J. Talley. Serotonergic and non‐serotonergic targets in the pharmacotherapy of visceral hypersensitivity. Neurogastroenterology & Motility 2007; 19(s1): 89 doi: 10.1111/j.1365-2982.2006.00876.x
150
Fang Yang, Nicholas Chia, Bryan A White, Lawrence B Schook. Compression-based distance (CBD): a simple, rapid, and accurate method for microbiota composition comparison. BMC Bioinformatics 2013; 14(1) doi: 10.1186/1471-2105-14-136
151
C. Chassard, M. Dapoigny, K. P. Scott, L. Crouzet, C. Del'homme, P. Marquet, J. C. Martin, G. Pickering, D. Ardid, A. Eschalier, C. Dubray, H. J. Flint, A. Bernalier‐Donadille. Functional dysbiosis within the gut microbiota of patients with constipated‐irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 2012; 35(7): 828 doi: 10.1111/j.1365-2036.2012.05007.x
152
Eamonn M.M. Quigley. Probiotics, Prebiotics, and Synbiotics. 2016; : 549 doi: 10.1016/B978-0-12-802189-7.00039-3
153
W.-T. Fan, C. Ding, N.-N. Xu, S. Zong, P. Ma, B. Gu. Close association between intestinal microbiota and irritable bowel syndrome. European Journal of Clinical Microbiology & Infectious Diseases 2017; 36(12): 2303 doi: 10.1007/s10096-017-3060-2
154
John Macsharry, Liam O'Mahony, Aine Fanning, Emer Bairead, Graham Sherlock, Jay Tiesman, Andy Fulmer, Barry Kiely, Timothy G. Dinan, Fergus Shanahan, Eamonn M. M. Quigley. Mucosal cytokine imbalance in irritable bowel syndrome. Scandinavian Journal of Gastroenterology 2008; 43(12): 1467 doi: 10.1080/00365520802276127
155
Caroline Codling, Liam O’Mahony, Fergus Shanahan, Eamonn M. M. Quigley, Julian R. Marchesi. A Molecular Analysis of Fecal and Mucosal Bacterial Communities in Irritable Bowel Syndrome. Digestive Diseases and Sciences 2010; 55(2): 392 doi: 10.1007/s10620-009-0934-x
156
Magdy El-Salhy, Trygve Hausken, Jan Gunnar Hatlebakk. Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS). Nutrients 2019; 11(6): 1415 doi: 10.3390/nu11061415
157
Julius Goepp, Elizabeth Fowler, Teresa Mcbride, Darryl Landis. Frequency of Abnormal Fecal Biomarkers in Irritable Bowel Syndrome. Global Advances in Health and Medicine 2014; 3(3): 9 doi: 10.7453/gahmj.2013.099
158
B.M. Sobieszczańska, J. Osek, D. Waśko-Czopnik, E. Dworniczek, K. Jermakow. Association of enteroaggregative Escherichia coli with irritable bowel syndrome. Clinical Microbiology and Infection 2007; 13(4): 404 doi: 10.1111/j.1469-0691.2006.01669.x
159
Acknowledgements. Expert Review of Gastroenterology & Hepatology 2013; 7(3): 289 doi: 10.1586/egh.12.9
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345